![PDF) Phase 1 dose-escalation study of the PARP inhibitor CEP-9722 as monotherapy or in combination with temozolomide in patients with solid tumors PDF) Phase 1 dose-escalation study of the PARP inhibitor CEP-9722 as monotherapy or in combination with temozolomide in patients with solid tumors](https://i1.rgstatic.net/publication/262784686_Phase_1_dose-escalation_study_of_the_PARP_inhibitor_CEP-9722_as_monotherapy_or_in_combination_with_temozolomide_in_patients_with_solid_tumors/links/549d0f070cf2b8037138c9c9/largepreview.png)
PDF) Phase 1 dose-escalation study of the PARP inhibitor CEP-9722 as monotherapy or in combination with temozolomide in patients with solid tumors
![TEMOZOLOMIDE 100MG <br> 5 Capsules/pack <br> Brand Name <br> ( TEMODAR 100MG ) <br> Teva 00093760157 TEMOZOLOMIDE 100MG <br> 5 Capsules/pack <br> Brand Name <br> ( TEMODAR 100MG ) <br> Teva 00093760157](https://sep.yimg.com/ay/yhst-12533177228474/temozolomide-100mg-5-capsules-pack-brand-name-temodar-100mg-teva-00093760157-22.gif)
TEMOZOLOMIDE 100MG <br> 5 Capsules/pack <br> Brand Name <br> ( TEMODAR 100MG ) <br> Teva 00093760157
![Temozolomide Increases the Number of Mismatch Repair–Deficient Intestinal Crypts and Accelerates Tumorigenesis in a Mouse Model of Lynch Syndrome - Gastroenterology Temozolomide Increases the Number of Mismatch Repair–Deficient Intestinal Crypts and Accelerates Tumorigenesis in a Mouse Model of Lynch Syndrome - Gastroenterology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/fc6d06e0-ea97-433c-8b3f-807f45e8ad24/gr1.jpg)
Temozolomide Increases the Number of Mismatch Repair–Deficient Intestinal Crypts and Accelerates Tumorigenesis in a Mouse Model of Lynch Syndrome - Gastroenterology
![TEMOZOLOMIDE 180MG <br> 5 Capsules/pack <br> Brand Name <br> ( TEMODAR 180MG ) <br> Teva 00093763957 TEMOZOLOMIDE 180MG <br> 5 Capsules/pack <br> Brand Name <br> ( TEMODAR 180MG ) <br> Teva 00093763957](https://sep.yimg.com/ay/yhst-12533177228474/temozolomide-180mg-5-capsules-pack-brand-name-temodar-180mg-teva-00093763957-28.gif)